KEY PRODUCTS
Maithri Drugs: Dedicated to your API needs.
01 1Maithri Drugs
01 1NITROFURANTOIN ANHYDROUS USP (MACROCRYSTALS)
01 1India
01 1Active
01 1Complete
Maithri Drugs: Dedicated to your API needs.
GDUFA
DMF Review : Complete
Rev. Date : 2025-02-05
Pay. Date : 2024-12-31
DMF Number : 34631
Submission : 2020-03-06
Status : Active
Type : II
20
Maithri Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Maithri Drugs: Dedicated to your API needs.
One of their notable products is NITROFURANTOIN ANHYDROUS USP (MACROCRYSTALS), with a corresponding US DMF Number 34631.
Remarkably, this DMF maintains an Active status since its submission on March 06, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2025, and payment made on December 31, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
